Results 151 to 160 of about 5,453 (193)

Cystic fibrosis alters the structure of the olfactory epithelium and the expression of olfactory receptors affecting odor perception. [PDF]

open access: yesSci Adv
Caballero I   +14 more
europepmc   +1 more source

Aérosolthérapie dans la mucoviscidose.

Revue des Maladies Respiratoires, 2008
Introduction La prescription de traitements par voie respiratoire est particulierement seduisante dans la mucoviscidose, malgre un depot pulmonaire tres heterogene et variable. Etat des connaissances Les traitements proposes sont essentiellement ceux ayant pour but d’ameliorer la qualite du mucus (serum sale hypertonique ou RhDNase en nebulisation,
J-C Dubus, S. Ravilly
openaire   +1 more source

Aspergillose et mucoviscidose

Archives de Pédiatrie, 2003
Allergic bronchopulmonary aspergillosis (ABPA) should be suspected in any CF patient whose pulmonary disease deteriorates precipitously, suddenly or unexpectedly, and has to be correlated to fungal hypersensitivity biological tests. The standard therapeutic approach is based upon systemic corticosteroids.
M Guillot   +4 more
openaire   +1 more source

Mucoviscidose et grossesse

Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 2005
Journal de Gynecologie Obstetrique et Biologie de la Reproduction - Vol. 34 - N° 7-C1 - p.
J. Pernaut   +3 more
openaire   +1 more source

Mucoviscidose et grossesse

Anesthésie & Réanimation, 2015
Introduction L’amelioration de la prise en charge de la mucoviscidose allonge l’esperance de vie des patientes. Les grossesses sont donc de plus en plus frequentes et constituent une periode a risque dans l’evolution de la maladie. Patientes et methodes Etude retrospective dans notre maternite de 1998 a 2013.
Iman Dira, Julien Corouge
openaire   +2 more sources

Mucoviscidose et rein

Néphrologie & Thérapeutique, 2009
Patients with cystic fibrosis (CF) show a continuing improvement in their life expectancy thanks to advances in knowledge of this disorder, allowing better multidisciplinary routine monitoring and earlier therapeutic interventions. Likewise, more than of 40% of these patients are adults and CF is no more only a pediatric disease.
Richard Montagnac   +4 more
openaire   +1 more source

Mucoviscidose

Revue de Pneumologie Clinique, 2007
D. Turck, L. Michaud
  +4 more sources

Home - About - Disclaimer - Privacy